betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas...
9
betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off